Efficacy and Mechanism Evaluation programme - Logo

News & Events

Quicklinks
 New funding stream for translational medicine
 Apply for Funding
The researcher-led workstream is currently open for outline applications.  This call will close at 1pm on 17 July 2012.
 Get Involved
Find out how to get involved with our work
 Resources
Useful links, FAQs and information to help with applications
 Join our mailing list
Latest News
 Treating severe fatigue in primary billary cirrhosis
 Lung volume reduction in COPD
 Provisional 2012 Commissioned Research Calls Announced
rss EME News Feed
twitter icon Follow NIHR on Twitter
 

 

Valid XHTML 1.0 Transitional

 

Plain English Campaign

 you are here › HomeNews & Events

Hope for Peanut Allergy Sufferers

3rd March 2009
The largest ever trial to find a treatment for peanut allergies has been funded by the EME programme.

Studies have shown that peanut allergies, the commonest cause of food-allergic reactions, affect two per cent of children in the UK.  Allergic reactions can cause breathing problems, itching and, in severe cases, a potentially fatal inflammatory reaction called anaphylaxis. Around one in ten reactions is serious.

The three-year trial, with EME funding of £671,247, will be lead by Dr Andrew Clark, a consultant in paediatric allergy from the University of Cambridge. This research is funded by the Medical Research Council and managed by the National Institute for Health Research.

This project is due to publish in 2013. To view full details about this project visit:

 http://www.eme.ac.uk/projectfiles/089918info.pdf (45kb) opens in a new window


 

page last updated
 printer friendly version   share Share

The Efficacy and Mechanism Evaluation programme is funded by the MRC and NIHR, with contributions from the CSO in Scotland and NISCHR in Wales and the HSC R&D, Public Health Agency in Northern Ireland. It is managed by the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) based at the University of Southampton.

University of Southampton - Logo